Elizabeth A. Whayland

Keine laufenden Positionen mehr

63 Jahre

Consumer Services

Health Technology

Commercial Services

Profil

Elizabeth A.
Whayland has been Senior Vice President of Finance for CuraGen Corp.
since October 2005 and Corporate Secretary since 1997.
Previously, she was Vice President of Finance for CuraGen from 2003 to September 2005 and Director of Financial Management from 1994 to 2002.
She was Senior Manager of Deloitte & Touche LLP.
Ms. Whayland received a BA from Grove City College and an MST from the University of Hartford.

Ehemalige bekannte Positionen von Elizabeth A. Whayland

Unternehmen	Position	Ende
CuraGen Corp. CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.	Finanzdirektor/CFO	01.01.2008
Deloitte & Touche LLP Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Elizabeth A. Whayland im Detail an

Ausbildung von Elizabeth A. Whayland

Grove City College	Undergraduate Degree
University of Hartford	Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Elizabeth A. Whayland im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
CuraGen Corp. CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.	Health Technology
Deloitte & Touche LLP Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.	Commercial Services

Sehen Sie sich die Unternehmensverbindungen an